Skip to main content
Q Bio
About Q Bio · Founded 2015 · Redwood City, California

Rebuilding the physical exam from the ground up.

Q Bio was founded to make comprehensive preventive health measurable and longitudinal — to help physicians and patients understand change in the body over time, not just at a single visit.

Read more about the Dashboard or how partners deploy it.

01 · Origin & mission

Why Q Bio exists.

Q Bio stands for quantitative biology: making preventive care measurable, longitudinal, and useful to patients, physicians, and partners.

Origin

Why we started.

The annual physical was built as an episodic snapshot, not as a longitudinal record of the body over time.

Mission

Quantitative biology, for preventive care.

Make a comprehensive longitudinal exam — measurable, comparable, physician-reviewed — at the scale premium care providers expect.

"The annual physical was designed for a different era. We rebuilt it for the age of longitudinal health."

Stanford University Harvard University Massachusetts General Hospital Massachusetts Institute of Technology
02 · What we built

One protocol. One product surface. One platform underneath.

The Q Exam, the Q Bio Health Dashboard, and the data infrastructure connecting them form a single deployable platform — delivered directly and through enterprise partners.

Product

Q Exam

Whole-body MRI, biomarkers, genetics, wearable data, and physician review — captured in a single visit.

See the Q Exam →
Product

Q Bio Health Dashboard

The longitudinal clinical interface that unifies every input into one record, for patients and clinicians.

See the Dashboard →
Infrastructure

Data & clinical platform

Imaging, biomarker, and genetic data ingestion, analysis workflows, and physician-review tooling.

Deployment

Partner model

The Q Exam delivered inside premium partners' clinical and brand experience — with Q Bio as the platform underneath.

See the partner model →
03 · Milestones

A decade of building the physical exam from the ground up.

Q Bio has spent more than ten years building the protocol, the data infrastructure, the Dashboard, and the partner model. A condensed milestone view.

2015

Q Bio founded

Founded with the mission of making the comprehensive physical exam measurable and longitudinal — and the work of building the platform begins.

2016 → 19

Platform development

Whole-body MRI protocol, biomarker integration, and the first versions of the Q Bio Health Dashboard developed and refined alongside clinical advisors.

2020

Q Bio Clinic opens in Redwood City

Q Bio's clinic opens in Redwood City — the operational home for the Q Exam and the proving ground for the protocol.

2021 → 23

Longitudinal scale

The Dashboard matures into a longitudinal clinical product — supporting comparison-over-time as members return for repeat exams.

2023

First enterprise customer deployment

The Q Exam is deployed inside the customer's health preventive care program — Q Bio as the protocol, data, and Dashboard layer beneath the partner's brand and clinical experience.

2024

FDA clearance

Q Bio's Constellation image-analysis software receives FDA 510(k) clearance — establishing the regulatory foundation for whole-body MRI analysis at clinical scale.

2024 → 26

Platform expansion

Continued investment in the multimodal record, partner deployment model, and the Q Bio Health Dashboard as the longitudinal product surface.

04 · Leadership

Interdisciplinary depth. Operating experience.

Q Bio's leadership brings together medicine, imaging, genomics, AI, operations, and commercialization — drawn from the institutions and companies that built and scaled modern healthcare.

President & CEO Jeffrey Brewer
  • Three operator exits
  • Regulatory and market-access scale-up across diabetes and consumer internet
Chief Medical Officer & Cofounder Garry Choy, MD/MBA
  • Former SVP & Deputy CMO, UnitedHealth Group
  • Board-certified radiologist; former Harvard Medical School faculty
Scientific Advisor & Cofounder Michael Snyder, PhD
  • Chair of Genetics and Professor of Genomics, Stanford.
  • Former director, Yale Center for Genomics and Proteomics
Chief Scientific Officer Thomas Witzel, PhD
  • Key role in development of the Connectome MRI scanner.
  • PhD, Harvard–MIT Health Sciences & Technology
Chief Financial Officer Brianna Hammer
  • Prior roles at Tribe Capital and Qatalyst Partners
  • MBA, UCLA Anderson
Chief Operating Officer George Zamanakos
  • Scaled connected health platforms at Abbott and Dexcom
  • Former medtech CEO; PhD, Caltech

Q Bio is the platform layer for longitudinal preventive health.

If you are building a premium preventive program — or you want to start your own longitudinal record — both paths begin here.